Focus Stocks
Eli Lilly Close to Support
Published on Monday, 08 February 2010 19:24 Written by Danny Miller
New York, Feb 8th (TradersHuddle.com) - Shares of Eli Lilly & Co. (NYSE:LLY) are trading very close to calculated support at $33.91 with current price action closing at just $34.78 places the stock price near levels where traders will start paying attention.
Eli Lilly (NYSE:LLY) principal activities are to develop, manufacture and market pharmaceutical-based health care solutions. The company specializes in research and development, production and marketing of products for the treatment of diabetes worldwide, such as insulin and insulin delivery devices.. Some of the company's patents include Zyprexa, Prozac, Permax, Humulin, Evista, Humalog, Humatrope, Vancocin, Keflex, Nebcin , Lorabid, Gemzar, Tylan, and Rumensin.
Eli Lilly's current stock range is defined by current calculated support defined at $33.91 and by the resistance level at $37.92, which should be used by traders planning their trades.
Traders wanting to establish a position should place close attention to Eli Lilly's price action, and establish
a position as close to support as possible, but only after buying materializes. Traders should understand that the resistance
point at $37.92 might limit their upside, however if the stock breaks resistance, it could be a good point to add to the position.
Related Articles
- Partnership Between Lilly Diabetes and the American Diabetes Association to Send 89 Children to American Diabetes Association Diabetes Camps in 2012
- Lilly Reports Fourth-Quarter and Full-Year 2011 Results
- FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for the treatment of adult patients with type 2 diabetes
- Eli Lilly Lower Ahead of Earnings
- Eli Lilly Closing in to Support?
- Eli Lilly Lower With High Volume
- /C O R R E C T I O N -- Eli Lilly and Company/
- Lilly Comments on 2011 Financial Guidance and Announces 2012 Financial Guidance
- A 52 Week High for Eli Lilly, will it Hold?
- Eli Lilly - 52 Week High
Related Partner Headlines
- UPDATE: Eli Lilly Reports 27% Decline In Q4 Profit - Benzinga
- From Earlier: FDA Approves Lilly's Jentadueto Tablets for the Treatment of Adult Patients with Type 2 Diabetes - Benzinga
- Eli Lilly And Stock Hits New 52-Week High (LLY) - TheStreet.com
- Eli Lilly And Company (LLY): Today's Featured Drugs Winner - TheStreet.com
- Eli Lilly And Stock Hits New 52-Week High (LLY) - TheStreet.com
- Eli Lilly And Company (LLY): Today's Featured Drugs Loser - TheStreet.com
- Eli Lilly And Company (LLY): Today's Featured Drugs Loser - TheStreet.com
- Bain Capital to Reacquire Physio-Control - TheStreet.com
- Eli Lilly And Company (LLY): Today's Featured Drugs Loser - TheStreet.com
- Eli Lilly And Stock To Go Ex-dividend Tomorrow (LLY) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Some Thoughts at the End of the 2011-2012 Football Season - Benzinga -
Benzinga's Microcap Movers for Monday February 6, 2012 - Benzinga -
ETFs to Watch February 7, 2012 - Benzinga -
Market Preview: Coke Lacks Fizz - TheStreet.com -
'Fast Money' Recap: Headwinds for Netflix? - TheStreet.com -
Benzinga's M&A Chatter for Monday February 6, 2012 - Benzinga -
Benzinga's M&A Chatter for Monday February, 2012 - Benzinga -
'Mad Money Lightning Round': Go With General Mills - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,845.13 Trade time:4:06PM EST Value change:▼17.10 (-0.13%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,344.33 Trade time:4:32PM EST Value change:▼0.57 (-0.04%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,901.99 Trade time:5:16PM EST Value change:▼3.67 (-0.13%)In The Wires
-
Fleishman-Hillard Takes Majority Interest in Leading Moscow Consultancy; Fleishman-Hillard Vanguard to Serve as Hub in CIS Countries -
Advanced Semiconductor Engineering, Inc. Announces Monthly Net Revenues -
QLogic Gains Fibre Channel Adapter Share in Calendar Year 2011, Marking Eighth Consecutive Year of Market Leadership -
ArcelorMittal Reports Fourth Quarter 2011 and Full Year 2011 Results -
Omega Announces Fourth Quarter 2011 Financial Results; Adjusted FFO of $0.50 Per Share for the Fourth Quarter; and $334 Million of New Investments -
Walmart Unveils “Great For You” Icon -
Nebraska Liquor Licenses Can Now be Renewed Online -
Analog Devices’ Webcast Addresses The Fundamentals Of Laying Out PC Boards










